Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
about
New Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of AutophagyHigh-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancerGene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeHigh-resolution genome-wide analysis identified recurrent genetic alterations in NK/T-cell lymphoma, nasal type, which are associated with disease progression.Virtual CGH: an integrative approach to predict genetic abnormalities from gene expression microarray data applied in lymphoma.Extranodal natural killer/T-cell lymphoma, nasal type, involving the skin, misdiagnosed as nasosinusitis and a fungal infection: A case report and literature review.A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.BIRC6 protein, an inhibitor of apoptosis: role in survival of human prostate cancer cellsDesign, Assessment, and in vivo Evaluation of a Computational Model Illustrating the Role of CAV1 in CD4(+) T-lymphocytes.Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targetsDNMT1 and AIM1 Imprinting in human placenta revealed through a genome-wide screen for allele-specific DNA methylation.Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.Autophagy as a therapeutic target in cancer.PRDM1 is a tumor suppressor gene in natural killer cell malignancies.The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal TypeGlobal promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma.AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcomeHypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC.HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasmsSynergistic combination therapy with nanoliposomal C6-ceramide and vinblastine is associated with autophagy dysfunction in hepatocarcinoma and colorectal cancer models.Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets.The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type.Autophagic cell death and cancer.Autophagy and tumorigenesisPathology and biology of peripheral T-cell lymphomas.Conversation between apoptosis and autophagy: "Is it your turn or mine?".Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.Peripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.PRDM1/Blimp-1 controls effector cytokine production in human NK cells.Whole transcriptome analysis reveals dysregulated oncogenic lncRNAs in natural killer/T-cell lymphoma and establishes MIR155HG as a target of PRDM1.Recurrent Cytogenetic Abnormalities in Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia.Methylation contributes to imbalance of PRDM1α/PRDM1bβ expression in diffuse large B-cell lymphoma.Genetic Landscape and Classification of Peripheral T Cell Lymphomas.Differential expression of aurora-A kinase in T-cell lymphomas.Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).
P2860
Q17149636-276077AB-9D55-404E-A936-A52211B28EB9Q54872411-38735A46-F8C9-4B76-8300-5FCF019A9A3DQ54899458-94C4365D-2DE2-4123-8598-CF02D35575BEQ54899912-22D0F08A-3DB3-4CD2-93C6-C3C8C290CBEAQ54930662-54A28AC3-B520-4DE8-BA75-C8060BDEA3BCQ54955063-E447CFD6-AD36-432E-8016-355C95E5EF36Q54955067-6D7EB06A-F948-4E59-B65F-62525A8A5527Q54995532-7FEF883E-90D1-4B3A-972A-BAA26BD690D2
P1343
Q26753053-FE783443-F5D1-408C-AD63-896BFD5C4568Q28480861-02D03056-5DD3-409B-B9AB-CF9818390A67Q33677463-99F1BF4B-8E4C-4CB6-8937-F92E052FD6DDQ33839279-BE381B4D-F268-440E-B9E5-6FC791E68125Q33870491-EC1660A2-31D9-4E94-ADD0-3C9DD75C41F0Q34293085-65C8995D-6FB6-4EEA-8258-BC066F1B0FECQ34310840-66B66AA9-1FEB-4475-B3D0-6D822BA4D932Q34586338-3A451EA6-21FD-4E38-B46E-40378AFCD473Q34637731-6580C007-7575-4C0C-B1C7-F4162A4D2E9DQ34898306-9D1CE72D-4D3E-4981-9233-9EEA2462202FQ35008254-AB7C470E-271C-4F20-8E2C-708D41385D64Q35152037-5204A04E-314F-4F26-9519-240B80EC0058Q35524194-093DF4E5-F4F4-4D17-937F-2B7CF1EBC4B1Q35591562-4BA3334B-3518-49F2-A8EA-084CDCD03DE6Q35647475-E253EC9D-1468-4AC2-9076-6429D1046D3EQ35843927-5540F570-E3C4-4414-90DC-91B3F458C149Q35859357-E7472BA4-C7A9-4CFD-866D-0AAC0F50D94AQ35962455-8A16C75A-0709-4F4D-8249-04F2146E4019Q36065290-DA30F158-9909-4C3B-A8F0-21FE5CAC36B3Q36259257-6D054211-6EAA-4FAD-B15F-90C4C7BB223DQ36495194-D0FA2665-BCC6-4B74-9855-D4FD9703F940Q37043008-A23E33C6-81B0-48E1-8AB2-630BCDFE4251Q37187642-E563FAB5-3365-4A7C-B417-661F80A0EA1FQ37504355-C51B46A6-CC1E-4240-937E-57E513836F59Q37645404-E5BD90D6-2CA5-474D-BD4C-89E2EFC2710CQ37662807-4CE5C0C8-C9ED-49C1-BFC0-6A7A9B992373Q37831955-8CD7F219-8AC4-4DEE-9F8F-5F2DE3EFF95EQ37853069-93D040E5-D154-4D0F-AD41-9BFFB30B8C83Q37863688-993E2534-3913-4733-8582-4FC860DA13A3Q38013696-C90223DC-E65B-4AC1-9BF7-F36218B8489AQ38043974-850A16D8-C4D9-4D59-9C38-67C0C4078DE9Q38179491-A7C9E560-BDC6-42FD-8F8C-160ED94041FEQ38289038-CB4E740A-280E-4CFE-BA09-3702D26A2A75Q38340188-EA995869-657F-44AB-915A-6996551420E0Q38705023-984AA75B-F3D2-4346-9BE8-28A255B86017Q38788221-8483F451-D7E7-4A75-9323-FD28276B67A5Q38930871-EFE83E20-3279-4951-8A50-A080126A1FE2Q39183278-30F38912-5205-46FE-831B-593D5B487562Q39194122-7C0E260F-ECAE-4BDB-AF1A-7C5E5FEFF699Q39284101-05DEB926-2C5C-4F4A-A582-CF1C30CF498F
P2860
Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Genomic analyses reveal global ...... ural killer-cell malignancies.
@en
Genomic analyses reveal global ...... ural killer-cell malignancies.
@nl
type
label
Genomic analyses reveal global ...... ural killer-cell malignancies.
@en
Genomic analyses reveal global ...... ural killer-cell malignancies.
@nl
prefLabel
Genomic analyses reveal global ...... ural killer-cell malignancies.
@en
Genomic analyses reveal global ...... ural killer-cell malignancies.
@nl
P2093
P4510
P356
P1433
P1476
Genomic analyses reveal global ...... tural killer-cell malignancies
@en
P2093
D Klinkebiel
G Srivastava
I F L Tsui
J K Christman
P2888
P304
P356
10.1038/LEU.2009.3
P577
2009-02-05T00:00:00Z
P5875
P6179
1020594435